Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market Set to Expand from USD 517.9M in 2024 to USD 812M by 2034

The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing market is estimated to account for USD 4.3 billion in 2025. It is anticipated to grow at a CAGR of 4.2% during the assessment period and reach a value of USD 6.5 billion by 2035. The methicillin-resistant Staphylococcus aureus (MRSA) treatment market is experiencing significant transformation due to …